The Reflexion Spiral Variable Radius features a circular loop at the tip that expands from 15 mm to 25 mm to fit a variety of patient anatomies. It is the only variable radius circular mapping catheter available with bi-directional deflection, which provides enhanced versatility for complex left atrial procedures. It also features the proprietary ComfortGrip(TM) handle to give physicians improved comfort and control during electrophysiology (EP) procedures.
Andrea Natale, M.D., of the Cleveland Clinic, one of the first physicians to use this product, said, "The ability of the catheter to deflect in both directions is a very useful benefit, and the handle proved extremely comfortable and easy to use."
The EnSite System provides highly detailed, three-dimensional (3-D) cardiac models that help physicians diagnose and treat many arrhythmias, including AF. The System is now available with a new computer, featuring twin dual-core processors for a dramatic improvement in processing speed. Many of the most complex processing and image rendering times have been reduced by up to 80 percent, allowing clinicians to obtain, display and analyze information faster than ever.
"The Boston Atrial Fibrillation Symposium brings together clinicians from around the world who are driving the innovation of curative approaches for this challenging and widespread condition," said Jane J. Song, president of St. Jude Medical's Atrial Fibrillation Division. "We look forward to collaborating with these leaders to develop technologies, procedures and clinical studies that support effective treatment of complex arrhythmias, including atrial fibrillation."
At the 2007 Boston AF Symposium, St. Jude Medical will also sponsor an educational symposium: "Evolving Approaches: The Next Generation of AF Management," which will be chaired by Warren Jackman, M.D., of the University of Oklahoma, Oklahoma City, and Douglas Packer, M.D., of the Mayo Foundation in Rochester, Minn., on Thursday, January 11.
About St. Jude Medical
St. Jude Medical is dedicated to making life better for cardiac, neurological and chronic pain patients worldwide through excellence in medical device technology and services. The Company has five major focus areas that include: cardiac rhythm management, atrial fibrillation, cardiac surgery, cardiology and neuromodulation. Headquartered in St. Paul, Minn., St. Jude Medical employs more than 11,000 people worldwide. For more information, please visit www.sjm.com.
Forward-Looking Statements
This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. Such forward-looking statements include the expectations, plans and prospects for the Company, including potential clinical successes, regulatory approvals, anticipated future product launches, revenues, margins, earnings, and market shares. The statements made by the Company are based upon management's current expectations and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include market conditions and other factors beyond the Company's control and the risk factors and other cautionary statements described in the Company's filings with the SEC, including those described in the Company's Annual Report on Form 10-K filed on March 16, 2006 (see Item 1A on pages 15-21) and in the Company's Quarterly Reports on Form 10-Q filed on August 7, 2006 (see Item 1A on page 32) and November 7, 2006 (see pages 31-32). The Company does not intend to update these statements and undertakes no duty to any person to provide any such update under any circumstance.
Contact: St. Jude Medical, Inc., St. Paul Investor Relations: Angela Craig, 651-481-7789 or Media Relations: Kathleen Janasz, 651-415-7042
Source: St. Jude Medical, Inc.
